Site Network Renew with clinicalRSVP.com's Research Participant Registry

Company News Release

clinicalRSVP.com, the participant registry that prevents research volunteers from enrolling in overlapping and concurrent research studies, announced that all seven (7) sites making up the original clinicalRSVP user network, including Clinical Pharmacology of Miami (one site), Comprehensive Clinical Development (three sites), Elite Research Institute (one site), and Seaview Research Inc. (two sites), have agreed to extend their commitment to the clinicalRSVP network through 2012 and beyond.

In 2009, this group of sites was the first in North America to adopt a subject registry for the purpose of preventing dual enrollment, thereby increasing data integrity and participant safety for their clients. Since inception, the clinicalRSVP network has grown to include 18 Phase I Units across the United States and Canada, representing more than 20 percent of the North American Phase I beds.

With ever-growing support from sponsors and sites alike, the mission of clinicalRSVP.com is to provide a single North American registry for investigators to confidentially and securely verify subject eligibility requirements prior to enrollment, thereby improving data integrity for sponsors and trial safety for participants.

“Ensuring our participants’ safety and facilitating rapid study start-up are the primary focuses for us at Comprehensive Clinical Development,” said Dr. Rae DelVecchio, Senior Vice President, Early Phase Operations. “We want our sponsors and participants to have total confidence in every aspect of our business and clinicalRSVP is a key component of our enrollment process.”